Navigation Links
Experimental Weight-Loss Pill Passes Early Test
Date:12/12/2008

People lost significant weight; no side effects on heart seen, study says

FRIDAY, Dec. 12 (HealthDay News) -- Researchers are hoping that an experimental new weight-loss drug will prove to be a valuable new weapon in the crusade against obesity.

In recently released phase 2 trials, the drug, known as lorcaserin, resulted in substantial weight loss in obese men and women.

"Lorcaserin is a completely novel mechanism and we think it can bring very robust weight loss. But, also, the safety profile of the compound is excellent," said Dominic P. Behan, co-founder and chief scientific officer of Arena Pharmaceuticals in San Diego, which makes the drug and sponsored a study published in the Dec. 4 issue of the journal Obesity.

"We demonstrated a highly statistically significant, progressive weight loss. This study involved no diet or exercise and the weight loss was rapid and we saw the weight loss in as little as two weeks," he added.

A phase 3 trial is under way and, if all goes well, Arena Pharmaceuticals may file a new drug application with the U.S. Food and Drug Administration at the end of 2009, Behan said.

With some two-thirds of Americans either overweight or obese, the need for an effective weight loss tool is tremendous. Excess weight can lead to a variety of health problems, including heart disease, stroke, cancer, arthritis and type 2 diabetes.

"Obesity is an epidemic," said Dr. Stuart Weiss, a clinical assistant professor of medicine at New York University's Langone Medical Center in New York City. "Diabetes trails behind obesity by a short few years and the numbers of patients that are developing diabetes is staggering."

Diet and exercise are proven antidotes for excess weight, but few people are able to sustain such changes and, even if they lose weight, will regain it.

Some weight-loss drugs are already on the market -- such as Xenical and Meridia
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Experimental Drug Fights Bone Marrow Cancers
2. Experimental Vaginal Gel Doesnt Ward Off HIV
3. Experimental TB drug explodes bacteria from the inside out
4. Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication
5. Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data
6. Experimental Apartment in Beijing Achieves 99% Purity of Indoor Air
7. Experimental Drug Fights Multiple Sclerosis Activity
8. Experimental Therapy Beats Back One Patients Melanoma
9. Experimental agent blocks prostate cancer in animal study
10. Experimental Drug Eases Symptoms of Mild Alzheimers
11. Experimental Blood Substitutes Unsafe, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... ... for LANDESK Management Suite customers, as part of the LANDESK One Partner ... IT, by delivering the best mobile user experience in remote access and control:, ...
(Date:9/3/2015)... ... 2015 , ... Advice columnist, professional life coach and entrepreneur ... Wasting Your Time Blaming Others for Your Life.” , Released just in time ... obstacles by taking full responsibility for one’s life shares 15 important life lessons ...
(Date:9/3/2015)... ... 03, 2015 , ... Girl’s Night Out to benefit Core Compassion Project will ... Kate Road in Monroe, North Carolina. The event food will be provided ... Kate Clyde’s offers off-premise catering and event services from casual to elegant. They are ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... Intellicure, Inc., in its Annual Inc. 5000 list of fastest-growing private companies ... "only a tiny fraction of the nation's companies have demonstrated such remarkably consistent ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... to healthcare providers, has been retained to lead a national chief executive ... top executive search firms in the healthcare industry, B. E. Smith has recently ...
Breaking Medicine News(10 mins):Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 3Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 4Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 3Health News:Girl’s Night Out, with Food From Kate Clyde's Catered Creations, to Benefit Core Compassion Project 2Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3
... Solutions , , HOUSTON, June 5 The ... for seniors, with over 500,000 members, has established two ... Retirement Planning. , , These two new divisions ... members, with the goal of better educating and empowering ...
... ... Harley Street based clinic - The London Clinic. The contract marks the world,s first live ... ... , a leading provider of clinical workflow and integration technology for the health care sector ...
... ... the privacy minded individual. , ... London, England (PRWEB) June 5, 2009 -- Best Pills Inc is proud ... bestpills.co.uk., , ,The site is unique in its offering of popularly prescribed "discreet" ...
... Inc. (NYSE: NUS ) today announced the board ... share, which will be paid on June 25, 2009, to ... The Company , For 25 years, Nu Skin ... its comprehensive anti-aging product portfolio, independent business opportunity and corporate ...
... Ortho Biotech Oncology Research & Development, a unit ... it has entered into a five-year Cooperative Research and ... with Steven A. Rosenberg, M.D., Ph.D., chief, Surgery Branch, ... develop novel cell therapy technologies as potential treatments for ...
... Pennsylvania, June 4 , ... Australian Sponsored,Publication Practices From 2000-2005 , ... scientific, technical and,medical (STM) information products and services, ... guidelines for its pharmaceutical services,divisions when producing reprints, ...
Cached Medicine News:Health News:Senior Citizens Bureau Creates New Resourceful Divisions 2Health News:Orion Health Live at Harley Street Clinic 2Health News:Orion Health Live at Harley Street Clinic 3Health News:Bestpills Launchs its New Online Pharmacy 2Health News:Ortho Biotech Oncology Research & Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 2Health News:Ortho Biotech Oncology Research & Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 3Health News:Ortho Biotech Oncology Research & Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 4Health News:Elsevier to Create New Guidelines for Pharmaceutical Article Reprint, Compilation and Custom Publications 2Health News:Elsevier to Create New Guidelines for Pharmaceutical Article Reprint, Compilation and Custom Publications 3
(Date:9/3/2015)... 2015 Research and ... of the "Investigation Report on China,s Progesterone ... The clinical demand for steroid drug is ... good efficacy especially its extended use in regulating ... years. Progesterone, a natural progestogen produced by ...
(Date:9/3/2015)... 03, 2015 Research and ... the "Investigation Report on China,s Raloxifene Market, 2010-2019" ... the statistics, over 200 million people suffer from osteoporosis ... in China , 50% have low ... among women aged 60 and above. Raloxifene (raloxifene ...
(Date:9/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/sd9xxh/radiology ) ... Systems Market by Type, Deployment Mode, End User and ... report to their offering. The ... Million 2014, and is projected to reach $722.7 Million ... to 2019. The global radiology information ...
Breaking Medicine Technology:China Progesterone Market Investigation Report 2015-2019 2Investigation Report on China's Raloxifene Market, 2015-2019 2Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 2Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 3
... Boston Scientific,Corporation (NYSE: BSX ) ... COGNIS(TM),cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN(TM),implantable ... platforms to treat heart failure and sudden ... multi-year research and development effort to provide,physicians ...
... CeloNova BioSciences, Inc.,("CeloNova"), leading and accelerating healthcare ... today announced breakthrough,results from the ATLANTA study ... Polyzene(R)-F at the 20th Annual International Symposium ... ), Corrado Tamburino, MD, President ...
Cached Medicine Technology:Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 2Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 3Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 4CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F 2
The Acute Care myoglobin method is an in vitro diagnostic test for the measurement of myoglobin in heparinized whole blood /plasma. Myoglobin measurements can be used as an aid in diagnosing myocardi...
... cardiac markers are available on ... Cardiac Troponin I (cTnI) is ... sensitivity and specificity for myocardial ... soon following AMI. CK-MB (mass) ...
... For the quantitative determination of myoglobin concentration ... ELISA test is based on the principle ... The assay system utilizes a unique monoclonal ... on the myoglobin molecule. Mouse monoclonal anti-myoglobin ...
Prolactin Radioimmunoassay...
Medicine Products: